Business Description
Cosmo NV
ISIN : NL0011832936
Share Class Description:
CMOPF: Registered SharesTotal Employee Number:
325Description
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 28.78 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.36 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 7.08 | |||||
Beneish M-Score | -4.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.3 | |||||
3-Year EBITDA Growth Rate | -37.4 | |||||
3-Year Book Growth Rate | 0.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 23.34 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.11 | |||||
9-Day RSI | 38.39 | |||||
14-Day RSI | 38.12 | |||||
3-1 Month Momentum % | -2.21 | |||||
6-1 Month Momentum % | -25.44 | |||||
12-1 Month Momentum % | 56.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.18 | |||||
Quick Ratio | 6.77 | |||||
Cash Ratio | 4.81 | |||||
Days Inventory | 82.36 | |||||
Days Sales Outstanding | 75.51 | |||||
Days Payable | 64.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.01 | |||||
3-Year Dividend Growth Rate | 26.8 | |||||
Forward Dividend Yield % | 3.01 | |||||
5-Year Yield-on-Cost % | 3.01 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 1.63 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.54 | |||||
Operating Margin % | -6.65 | |||||
Net Margin % | -3.47 | |||||
EBITDA Margin % | 11.48 | |||||
FCF Margin % | -17.32 | |||||
OCF Margin % | -12.09 | |||||
ROE % | -0.75 | |||||
ROA % | -0.58 | |||||
ROIC % | -1.49 | |||||
3-Year ROIIC % | 14.38 | |||||
ROC (Joel Greenblatt) % | -1.75 | |||||
ROCE % | -0.14 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 796.12 | |||||
Shiller PE Ratio | 200 | |||||
PS Ratio | 10.8 | |||||
PB Ratio | 2.37 | |||||
Price-to-Tangible-Book | 8.64 | |||||
EV-to-EBIT | -1369.92 | |||||
EV-to-Forward-EBIT | -1107.05 | |||||
EV-to-EBITDA | 91.05 | |||||
EV-to-Forward-EBITDA | 92.25 | |||||
EV-to-Revenue | 10.45 | |||||
EV-to-Forward-Revenue | 10.44 | |||||
EV-to-FCF | -60.35 | |||||
Price-to-GF-Value | 1.53 | |||||
Price-to-Projected-FCF | 1.7 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
| Price-to-Net-Current-Asset-Value | 21.58 | |||||
Earnings Yield (Greenblatt) % | -0.07 | |||||
FCF Yield % | -1.51 | |||||
Forward Rate of Return (Yacktman) % | 13.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CMOPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cosmo NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 121.076 | ||
| EPS (TTM) ($) | -0.262 | ||
| Beta | 0.9217 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 0.98 | ||
| Volatility % | 75.01 | ||
| 14-Day RSI | 38.12 | ||
| 14-Day ATR ($) | 3.525749 | ||
| 20-Day SMA ($) | 88.13415 | ||
| 12-1 Month Momentum % | 56.37 | ||
| 52-Week Range ($) | 64.37 - 169.9 | ||
| Shares Outstanding (Mil) | 17.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cosmo NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cosmo NV Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| EUR 2.100000 Cash Dividend | 2026-04-24 | 122.70 (+2.89%) | ||
| EUR 2.050000 Cash Dividend | 2025-06-04 | 64.37 (+0.00%) | ||
| EUR 2.000000 Cash Dividend | 2024-07-10 | 80.25 (+0.00%) |
Show
Entries
Cosmo NV Frequently Asked Questions
What is Cosmo NV(CMOPF)'s stock price today?
The current price of CMOPF is $82.00. The 52 week high of CMOPF is $169.90 and 52 week low is $64.37.
When is next earnings date of Cosmo NV(CMOPF)?
The next earnings date of Cosmo NV(CMOPF) is .
Does Cosmo NV(CMOPF) pay dividends? If so, how much?
The Dividend Yield %  of Cosmo NV(CMOPF) is 3.01% (As of Today), Highest Dividend Payout Ratio of Cosmo NV(CMOPF) was 1.1. The lowest was 0.25. And the median was 0.91. The  Forward Dividend Yield % of Cosmo NV(CMOPF) is 3.01%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:CMOPF
No articles.
Press Release
Articles on Cosmo NV
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers